Cochrane COVID-19 Studienregister
Studienbericht
NCT05075304Erstmals veröffentlicht: 2021 Okt 12Letzte Aktualisierung: 2021 Okt 12

A Phase Ib, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of BDB-001 Injection in Patients With Novel Coronavirus (2019-nCoV) Infection

  1. Studientyp
  2. Interventional
  1. Studienziel
  2. Treatment and Management
  1. Studiendesign
  2. Other
  1. Interventionszuordnung
  2. Non-randomised
Referenzdatensätze

A Safety and Tolerability Study of BDB-001 in Mild, Moderate COVID-19 Patients

Staidson (Beijing) Biopharmaceuticals Co., Ltd
Erstmals veröffentlicht (first received 2021 October 12)ClinicalTrials.gov (https://clinicaltrials.gov/show/NCT05075304)
Eintrag in Studienregister
Keine Ergebnisse
This open, multi-center, multiple ascending dose study was designed to evaluate the safety, tolerability, preliminary efficacy and PK/PD of BDB-001 injection in patients with mild, or general COVID-19